AGP Executive Report
Last update: 10 hours agoAI and Medication Safety: In a South Korean survey, half of people who changed or stopped medication on chatbot advice reported side effects; health professionals remain essential for treatment decisions. Medicine Shortages: South Africa says 30 medicine shipments are waiting at Durban port, as national availability falls to 83.4%. Shortages are also pushing pharmacists in Ireland toward unlicensed substitutes, while Sri Lankan specialists warn that unqualified medicine sellers may be fueling antibiotic misuse and resistance. GLP-1 Warning: Oman’s health ministry flagged a rare risk of sudden vision loss linked to several GLP-1 medicines and tirzepatide. Patients should seek urgent care for vision changes and consult their doctor before changing treatment. Drug Development: Arcera and Innogen signed an exclusive deal to bring a GLP-1 therapy for cardiometabolic disease to selected markets in Africa, Eastern Europe, Latin America and the Middle East.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.